Literature DB >> 17465864

Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer.

Sang-Woo Lee1, Jaetae Lee, Hui Joong Lee, Ji-Hyoung Seo, Seong-Min Kang, Jin-Ho Bae, Byeong-Cheol Ahn.   

Abstract

OBJECTIVE: The exact prevalence and clinical significance of ectopic thyroid or thyroglossal duct remnant (TGDR) in the general population have not yet been fully determined despite numerous case reports. This study was prepared to assess the prevalence of TGDR in asymptomatic subjects during hypothyroidism after a total thyroidectomy for differentiated thyroid cancer (DTC) and to clarify the clinical implication.
DESIGN: Tc-99m pertechnetate scintigraphy (Tc-scan) of the head and neck before radioiodine ablation therapy and whole-body and pinhole I-131 scintigraphy (I-scan) after ablation therapy were reviewed for 131 consecutive DTC patients with hypothyroidism after a total thyroidectomy. MAIN OUTCOME: Forty-four among the 131 patients (33.6%) revealed an unexpected linear or focal radioactivity at the anterior midline of the neck, suggesting the presence of TGDR. The Tc-scan and pinhole I-scan were concordant in all cases of abnormal midline neck uptake, although the planar I-scan failed to delineate TGDR due to prominent photon scattering in most cases. Preoperative enhanced neck computed tomography scan was performed in 49 patients and showed no evidence of thyroid glandular tissue separated from thyroid gland in midline of the anterior neck except 1 case. The success rate after radioiodine ablation did not differ significantly between the positive and negative TGDR patients.
CONCLUSIONS: TGDR can be frequently observed in scintigraphy of hypothyroid subjects after a thyroidectomy, even when clinically unexpected. Therefore, care should be taken not to confuse the tracer uptake by TGDR with metastatic foci in I- and Tc-scans of patients with hypothyroidism after a thyroidectomy for DTC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465864     DOI: 10.1089/thy.2006.0274

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  SPECT/CT imaging in children with papillary thyroid carcinoma.

Authors:  Hwa-Young Kim; Michael J Gelfand; Susan E Sharp
Journal:  Pediatr Radiol       Date:  2011-05-24

2.  Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma.

Authors:  Geum-Cheol Jeong; Minchul Song; Hee Jeong Park; Jung-Joon Min; Hee-Seung Bom; Sang-Geon Cho; Ki Seong Park; Sae-Ryung Kang; Jahae Kim; Ho-Chun Song; Seong Young Kwon
Journal:  Nucl Med Mol Imaging       Date:  2016-05-13

3.  Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation.

Authors:  Mohamed Hosny Mohamed Sayed; Hussein Rabie Saleh Farghaly; Fahd Ahmad Fadl
Journal:  Indian J Nucl Med       Date:  2015 Apr-Jun

4.  Prevalence and Features of Thyroglossal Duct Cyst on Ultrasonography, According to Radioactive Iodine Therapy: A Single-Center Study.

Authors:  Ji Sun Park; Dong Wook Kim; Gi Won Shin; Jin Young Park; Yoo Jin Lee; Hye Jung Choo; Ha Kyoung Park; Tae Kwun Ha; Do Hun Kim; Soo Jin Jung; Sung Ho Moon; Ki Jung Ahn; Hye Jin Baek
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-03       Impact factor: 5.555

5.  Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma.

Authors:  Su Woong Yoo; Md Sunny Anam Chowdhury; Subin Jeon; Sae-Ryung Kang; Sang-Geon Cho; Jahae Kim; Changho Lee; Young Jae Ryu; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

6.  A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer.

Authors:  Hong Hua Piao; Subin Jeon; Su Woong Yoo; Young Jae Ryu; Dong-Yeon Kim; Ayoung Pyo; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Diagnostics (Basel)       Date:  2021-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.